Parliamentary Activity
COVID-19 Inquiry — 234 mentions in Parliament since Jul 2020
Paxlovid and clinically vulnerable patients
That this House calls on the Secretary of State for Health and Social Care to reject the request from NHS England to delay the roll-out of Covid antiviral treatment Paxlovid; further calls for the additional funds and resources necessary to be provided to NHS England to ensure this treatment reaches all recommended patients this winter; notes with grave concern that a 12 month delay would deny treatment to an estimated 10 million patients at high and moderate risk of hospitalisation and death...
Measures to enable immunocompromised and immunosuppressed patients to live with covid-19
That this House regrets the continued failure of Government to protect people who have moderate to severe immune compromise from covid-19 infection, by failing to make Evusheld available on the NHS when it was at its most effective against covid strains; notes with alarm the disbandment of the Enhanced Protection Programme, Covid-19 Antivirals and Therapeutics Taskforce, ONS Covid-19 Infection Survey and the closure of Covid Medicine Delivery Units since 31 March 2023; deeply regrets that pat...